Integra Lifesciences Holdings Corp
IART
Market Cap$2.49B
Close$
$36.71
29.2% upside
Current Fair Value
29.2% upsideUndervalued by 29.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.49 Billion |
|---|---|
| Enterprise Value | $3.68 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.84 |
| Beta | 1.38 |
| Outstanding Shares | 78,602,240 |
| Avg 30 Day Volume | 648,785 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 36.7 |
|---|---|
| PEG | -58.69 |
| Price to Sales | 1.5 |
| Price to Book Ratio | 1.42 |
| Enterprise Value to Revenue | 2.38 |
| Enterprise Value to EBIT | 32.97 |
| Enterprise Value to Net Income | 54 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 0.94 |
Revenue Sources
No data
ESG Score
No data
About Integra Lifesciences Holdings Corp
CEO: Peter Arduini